D.E. Shaw & Co’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Sell
277,381
-69,164
-20% -$373K ﹤0.01% 3286
2025
Q4
$2.2M Sell
346,545
-199,638
-37% -$1.39M ﹤0.01% 2979
2025
Q3
$5.1M Sell
546,183
-1,055,625
-66% -$10.7M ﹤0.01% 2193
2025
Q2
$23.1M Buy
1,601,808
+318,018
+25% +$3.14M 0.02% 950
2025
Q1
$8.86M Buy
1,283,790
+272,500
+27% +$1.71M 0.01% 1487
2024
Q4
$5.36M Buy
1,011,290
+957,665
+1,786% +$5.24M 0.01% 1920
2024
Q3
$196K Buy
+53,625
New +$169K ﹤0.01% 4167
2023
Q3
Sell
-37,694
Closed -$59.2K 4591
2023
Q2
$59.2K Sell
37,694
-58,319
-61% -$87K ﹤0.01% 3867
2023
Q1
$147K Sell
96,013
-60,433
-39% -$108K ﹤0.01% 3951
2022
Q4
$263K Buy
156,446
+63,914
+69% +$101K ﹤0.01% 4144
2022
Q3
$114K Buy
92,532
+25,208
+37% +$40.6K ﹤0.01% 4580
2022
Q2
$112K Sell
67,324
-18,171
-21% -$35.5K ﹤0.01% 4706
2022
Q1
$210K Buy
85,495
+23,453
+38% +$64.1K ﹤0.01% 4842
2021
Q4
$232K Buy
62,042
+15,226
+33% +$82.2K ﹤0.01% 4807
2021
Q3
$294K Sell
46,816
-41,336
-47% -$341K ﹤0.01% 4364
2021
Q2
$869K Buy
+88,152
New +$769K ﹤0.01% 3660

Other funds holding NAGE